Exact Sciences Stock Buy Hold or Sell Recommendation
| EXAS Stock | USD 55.14 2.23 4.21% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding EXACT Sciences is 'Strong Sell'. A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell EXACT Sciences given historical horizon and risk tolerance towards EXACT Sciences. When Macroaxis issues a 'buy' or 'sell' recommendation for EXACT Sciences, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out EXACT Sciences Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For more information on how to buy EXACT Stock please use our How to Invest in EXACT Sciences guide. Note, we conduct extensive research on individual companies such as EXACT and provide practical buy, sell, or hold advice based on investors' constraints. EXACT Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
EXACT |
Execute EXACT Sciences Buy or Sell Advice
The EXACT recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on EXACT Sciences. Macroaxis does not own or have any residual interests in EXACT Sciences or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute EXACT Sciences' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Very steady | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Below Average | Details | |
Economic Sensitivity | Very regressive towards the market | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Poor | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
EXACT Sciences Trading Alerts and Improvement Suggestions
| EXACT Sciences generated a negative expected return over the last 90 days | |
| EXACT Sciences has high historical volatility and very poor performance | |
| The company reported the previous year's revenue of 2.5 B. Net Loss for the year was (204.15 M) with profit before overhead, payroll, taxes, and interest of 1.51 B. | |
| EXACT Sciences has a poor financial position based on the latest SEC disclosures | |
| Over 99.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from news.google.com: Swiss National Bank Increases Holdings in Exact Sciences Co. - MarketBeat |
EXACT Sciences Returns Distribution Density
The distribution of EXACT Sciences' historical returns is an attempt to chart the uncertainty of EXACT Sciences' future price movements. The chart of the probability distribution of EXACT Sciences daily returns describes the distribution of returns around its average expected value. We use EXACT Sciences price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of EXACT Sciences returns is essential to provide solid investment advice for EXACT Sciences.
| Mean Return | -0.08 | Value At Risk | -3.29 | Potential Upside | 6.01 | Standard Deviation | 4.00 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of EXACT Sciences historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
EXACT Stock Institutional Investors
The EXACT Sciences' institutional investors refer to entities that pool money to purchase EXACT Sciences' securities or originate loans. These institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds.
| Shares | Morgan Stanley - Brokerage Accounts | 2024-06-30 | 2.9 M | Champlain Investment Partners, Llc | 2024-09-30 | 2.5 M | Ameriprise Financial Inc | 2024-06-30 | 2.2 M | Holocene Advisors, Lp | 2024-09-30 | 1.9 M | Macquarie Group Ltd | 2024-06-30 | 1.5 M | Cam Group Holding A/s | 2024-09-30 | 1.5 M | Bellevue Group Ag | 2024-09-30 | 1.4 M | Zevenbergen Capital Investments Llc | 2024-09-30 | 1.4 M | Mackenzie Investments | 2024-09-30 | 1.4 M | Fmr Inc | 2024-09-30 | 21.6 M | Vanguard Group Inc | 2024-09-30 | 17.8 M |
EXACT Sciences Cash Flow Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change In Cash | 17.1M | 1.3B | (1.2B) | (73.0M) | 366.9M | 385.2M | |
| Free Cash Flow | (286.8M) | 72.1M | (238.0M) | (438.0M) | 31.9M | 33.5M | |
| Depreciation | 50.2M | 163.4M | 180.3M | 197.6M | 206.6M | 216.9M | |
| Other Non Cash Items | 48.9M | 721.3M | 202.0M | 33.8M | (76.4M) | (72.5M) | |
| Capital Expenditures | 171.8M | 64.4M | 135.8M | 214.5M | 124.2M | 130.4M | |
| Net Income | (84.0M) | (848.5M) | (595.6M) | (623.5M) | (204.1M) | (214.4M) | |
| End Period Cash Flow | 177.5M | 1.5B | 315.8M | 242.8M | 609.7M | 640.2M | |
| Change To Inventory | (19.0M) | (30.3M) | (9.2M) | (13.2M) | (7.7M) | (8.1M) | |
| Investments | 1.0B | (219.2M) | (387.8M) | 278.8M | 49.7M | 52.2M | |
| Dividends Paid | 17.2M | 18.4M | 37.5M | 169.5M | 194.9M | 108.4M | |
| Change To Netincome | 106.5M | 777.6M | 195.3M | 181.3M | 208.5M | 131.1M | |
| Net Borrowings | 236.4M | 975.5M | (23.7M) | 50M | 57.5M | 54.6M | |
| Change Receivables | (27.9M) | (100.5M) | 25.2M | 61.1M | 70.3M | 73.8M |
EXACT Sciences Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to EXACT Sciences or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that EXACT Sciences' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a EXACT stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.1 | |
β | Beta against Dow Jones | -1.57 | |
σ | Overall volatility | 4.12 | |
Ir | Information ratio | -0.05 |
EXACT Sciences Volatility Alert
EXACT Sciences exhibits very low volatility with skewness of -2.63 and kurtosis of 18.08. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure EXACT Sciences' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact EXACT Sciences' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.EXACT Sciences Fundamentals Vs Peers
Comparing EXACT Sciences' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze EXACT Sciences' direct or indirect competition across all of the common fundamentals between EXACT Sciences and the related equities. This way, we can detect undervalued stocks with similar characteristics as EXACT Sciences or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of EXACT Sciences' fundamental indicators could also be used in its relative valuation, which is a method of valuing EXACT Sciences by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare EXACT Sciences to competition |
| Fundamentals | EXACT Sciences | Peer Average |
| Return On Equity | -0.0676 | -0.31 |
| Return On Asset | -0.0216 | -0.14 |
| Profit Margin | (0.08) % | (1.27) % |
| Operating Margin | (0.03) % | (5.51) % |
| Current Valuation | 11.53 B | 16.62 B |
| Shares Outstanding | 185.08 M | 571.82 M |
| Shares Owned By Insiders | 1.01 % | 10.09 % |
| Shares Owned By Institutions | 98.99 % | 39.21 % |
| Number Of Shares Shorted | 14.06 M | 4.71 M |
| Price To Earning | (38.17) X | 28.72 X |
| Price To Book | 3.05 X | 9.51 X |
| Price To Sales | 3.64 X | 11.42 X |
| Revenue | 2.5 B | 9.43 B |
| Gross Profit | 1.51 B | 27.38 B |
| EBITDA | 41.88 M | 3.9 B |
| Net Income | (204.15 M) | 570.98 M |
| Cash And Equivalents | 728.04 M | 2.7 B |
| Cash Per Share | 4.11 X | 5.01 X |
| Total Debt | 2.55 B | 5.32 B |
| Debt To Equity | 0.77 % | 48.70 % |
| Current Ratio | 2.48 X | 2.16 X |
| Book Value Per Share | 17.35 X | 1.93 K |
| Cash Flow From Operations | 156.12 M | 971.22 M |
| Short Ratio | 9.68 X | 4.00 X |
| Earnings Per Share | (1.16) X | 3.12 X |
| Price To Earnings To Growth | (1.07) X | 4.89 X |
| Target Price | 70.14 | |
| Number Of Employees | 6.5 K | 18.84 K |
| Beta | 1.27 | -0.15 |
| Market Capitalization | 9.79 B | 19.03 B |
| Total Asset | 6.47 B | 29.47 B |
| Retained Earnings | (3.47 B) | 9.33 B |
| Working Capital | 679.67 M | 1.48 B |
Note: Disposition of 929 shares by Brian Baranick of EXACT Sciences at 70.0 subject to Rule 16b-3 [view details]
EXACT Sciences Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as EXACT . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About EXACT Sciences Buy or Sell Advice
When is the right time to buy or sell EXACT Sciences? Buying financial instruments such as EXACT Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having EXACT Sciences in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Materials ETFs Thematic Idea Now
Materials ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Materials ETFs theme has 51 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Materials ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for EXACT Stock Analysis
When running EXACT Sciences' price analysis, check to measure EXACT Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy EXACT Sciences is operating at the current time. Most of EXACT Sciences' value examination focuses on studying past and present price action to predict the probability of EXACT Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move EXACT Sciences' price. Additionally, you may evaluate how the addition of EXACT Sciences to your portfolios can decrease your overall portfolio volatility.